VOR vs. OPAD

Last updated Jun 4, 2026

VOR (Vor Biopharma Inc.) and OPAD (Offerpad Solutions Inc.) are both stocks. VOR operates in Biotechnology (Healthcare), while OPAD operates in Real Estate - Services (Real Estate). Over the past 5 years, VOR returned -49.48%/yr vs -65.18%/yr for OPAD. At a 0.15 correlation, their price movements are largely independent.

Performance

VOR vs. OPAD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vor Biopharma Inc. (VOR) and Offerpad Solutions Inc. (OPAD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VOR achieves a 2.75% return, which is significantly higher than OPAD's -37.12% return.

VOR

• 1D: -1.61%
• 1M: -8.63%
• YTD: 2.75%
• 6M: 57.93%
• 1Y: 203.25%
• 3Y*: -48.25%
• 5Y*: -49.48%
• 10Y*: —

OPAD

• 1D: -7.21%
• 1M: 11.90%
• YTD: -37.12%
• 6M: -58.42%
• 1Y: -23.14%
• 3Y*: -55.19%
• 5Y*: -65.18%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

VOR vs. OPAD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
VOR Vor Biopharma Inc.	2.75%	-41.08%	-50.67%	-66.17%	-42.77%	-69.01%
OPAD Offerpad Solutions Inc.	-37.12%	-57.54%	-72.20%	48.39%	-92.80%	-43.26%

Correlation

The correlation between VOR and OPAD is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.13
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (All Time) Calculated using the full available price history since Feb 8, 2021	0.15

Fundamentals

Market Cap VOR : $578.08M OPAD : $35.15M
EPS VOR : -$53.66 OPAD : -$1.16
Total Revenue (TTM) VOR : $0.00 OPAD : $487.19M
Gross Profit (TTM) VOR : -$23.00K OPAD : $37.09M
EBITDA (TTM) VOR : -$1.13B OPAD : -$29.30M

Return for Risk

VOR vs. OPAD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VOR

VOR Risk / Return Rank: 78
VOR Sharpe Ratio Rank: 75
VOR Sortino Ratio Rank: 87
VOR Omega Ratio Rank: 84
VOR Calmar Ratio Rank: 77
VOR Martin Ratio Rank: 68

OPAD

OPAD Risk / Return Rank: 46
OPAD Sharpe Ratio Rank: 36
OPAD Sortino Ratio Rank: 66
OPAD Omega Ratio Rank: 61
OPAD Calmar Ratio Rank: 32
OPAD Martin Ratio Rank: 34

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VOR vs. OPAD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vor Biopharma Inc. (VOR) and Offerpad Solutions Inc. (OPAD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	VOR	OPAD	Difference
Sharpe ratio: Return per unit of total volatility	1.19	-0.11	+1.31
Sortino ratio: Return per unit of downside risk	2.93	1.59	+1.33
Omega ratio: Gain probability vs. loss probability	1.35	1.17	+0.18
Calmar ratio: Return relative to maximum drawdown	2.35	-0.26	+2.60
Martin ratio: Return relative to average drawdown	3.44	-0.34	+3.78
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

VOR vs. OPAD - Sharpe Ratio Comparison

The current VOR Sharpe Ratio is 1.19, which is higher than the OPAD Sharpe Ratio of -0.11. The chart below compares the historical Sharpe Ratios of VOR and OPAD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	VOR	OPAD	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.19	-0.11	+1.31
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.43	-0.50	+0.07
Sharpe Ratio (All Time) Calculated using the full available price history	-0.46	-0.50	+0.04

Drawdowns

VOR vs. OPAD - Drawdown Comparison

The maximum VOR drawdown since its inception was -99.72%, roughly equal to the maximum OPAD drawdown of -99.81%. Use the drawdown chart below to compare losses from any high point for VOR and OPAD.

Drawdown Indicators

	VOR	OPAD	Difference
Max Drawdown Largest peak-to-trough decline	-99.72%	-99.81%	+0.09%
Max Drawdown (1Y) Largest decline over 1 year	-87.15%	-90.75%	+3.60%
Max Drawdown (3Y) Largest decline over 3 years	-97.16%	-96.10%	-1.06%
Max Drawdown (5Y) Largest decline over 5 years	-99.32%	-99.81%	+0.49%
Current Drawdown Current decline from peak	-98.76%	-99.75%	+0.99%
Average Drawdown Average peak-to-trough decline	-88.70%	-82.04%	-6.66%
Ulcer Index Depth and duration of drawdowns from previous peaks	59.44%	67.36%	-7.92%

Volatility

VOR vs. OPAD - Volatility Comparison

Vor Biopharma Inc. (VOR) and Offerpad Solutions Inc. (OPAD) have volatilities of 21.24% and 22.32%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VOR	OPAD	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.24%	22.32%	-1.08%
Volatility (6M) Calculated over the trailing 6-month period	72.85%	73.35%	-0.50%
Volatility (1Y) Calculated over the trailing 1-year period	171.45%	209.29%	-37.84%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	116.42%	130.96%	-14.54%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	116.84%	125.34%	-8.50%

Dividends

VOR vs. OPAD - Dividend Comparison

Neither VOR nor OPAD has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both VOR and OPAD in my portfolio?

VOR and OPAD have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VOR or OPAD?

OPAD has higher volatility (22.32%) compared to VOR (21.24%). In terms of maximum drawdown, VOR dropped -99.72% vs OPAD's -99.81%.

Which has better risk-adjusted returns?

VOR currently has the higher Sharpe Ratio (1.19 vs -0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.